 |
|
|
|
|
|
|
|
|
|
|
|
Call to Order and Opening Remarks |
|
|
| |
Diane Wara, M.D., Chair, NIH RAC |
|
|
| |
Webcast
|
|
| |
|
|
|
Minutes of the March 16, 2005, RAC Meeting |
|
|
| |
RAC Reviewers: Nicholas Muzyczka, Ph.D. and Emmett Barkley, Ph.D. |
|
|
| |
Webcast
|
|
| |
|
|
|
Certificates of Appreciation |
|
|
| |
Raynard S. Kington, M.D., Ph.D., Deputy Director, National Institutes of Health |
|
|
| |
Webcast
|
|
| |
|
|
|
Followup from March 15, 2005, Gene Transfer Safety Symposium:Current Perspectives on Gene Transfer for X-SCID |
|
|
| |
Diane Wara, M.D. and Marina O�Reilly, Ph.D., Office of Biotechnology Activities |
|
|
| |
Webcast
|
|
| |
|
|
|
|
Discussion of Human Gene Transfer Protocol #0311-613 |
|
|
| |
Phase I Dose-Escalation Study of Intratumoral Herpes Simplex Virus-1 Mutant rRp450 in Patients with Refractory Sarcoma or Neuroblastoma |
|
|
| |
Timothy P. Cripe, M.D., Ph.D., Cincinnati Children�s Hospital Medical Center, Cincinnati, OH |
|
|
| |
Slides
Webcast
|
|
| |
|
|
|
|
Discussion of Human Gene Transfer Protocol #0502-699 |
|
|
| |
A Pilot Study of Temozolomide and O 6-Benzylguanine for Treatment of High-Grade Glioma Using Autologous Peripheral Blood Stem Cells Genetically Modified for Chemoprotection |
|
|
| |
Lars Martin Wagner, M.D., Cincinnati Children�s Hospital Medical Center/University of Cincinnati College of Medicine, Cincinnati, OH |
|
|
| |
Slides
Webcast
|
|
| |
|
|
|
Data Management Report |
|
|
| |
RAC Reviewers: Steven Albelda, M.D., Helen Heslop, M.D., Robert Simari, M.D., and Diane Wara, M.D. |
|
|
| |
Webcast
|
|
| |
|
|
|
|
Discussion of Human Gene Transfer Protocol #0504-703 |
|
|
| |
Phase I Safety, Dose-Escalating Study of MultiGeneAngio in Patients with Peripheral Arterial Disease |
|
|
| |
P. Michael Grossman, M.D., University of Michigan/VA Ann Arbor Health Systems, Ann Arbor, MI |
|
|
| |
Slides
Webcast
|
|
| |
|
|
|
ADJOURN |
|
| |
